Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-25 8:01 pm Sale |
2024-03-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 3,992,586 9.900% |
-2,684,347 (-40.20%) |
Filing History |
| 2024-04-25 7:39 pm Sale |
2024-03-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 926,016 1.340% |
-1,573,977 (-62.96%) |
Filing History |
| 2024-04-25 7:30 pm Unchanged |
2024-03-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 8,988,318 9.900% |
0 (Unchanged) |
Filing History |
| 2024-04-25 7:22 pm Purchase |
2024-03-31 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors, Inc. | 485,990 6.920% |
6,000 (+1.25%) |
Filing History |
| 2024-04-25 7:13 pm Unchanged |
2024-03-31 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 4,575,385 9.900% |
0 (Unchanged) |
Filing History |
| 2024-04-25 7:01 pm Sale |
2024-03-31 | 13G | OptiNose, Inc. OPTN |
Rosalind Advisors, Inc. | 302,766 5.140% |
-22,939 (-7.04%) |
Filing History |
| 2024-04-25 6:52 pm Sale |
2024-03-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 1,508,419 3.670% |
-813,581 (-35.04%) |
Filing History |
| 2024-03-25 6:55 pm Purchase |
2024-03-19 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 2,952,202 9.900% |
541,678 (+22.47%) |
Filing History |
| 2024-03-21 09:05 am Unchanged |
2024-03-20 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors, Inc. | 504,261 9.900% |
0 (Unchanged) |
Filing History |
| 2024-03-20 9:21 pm Purchase |
2024-03-20 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors, Inc. | 504,261 9.900% |
504,261 (New Position) |
Filing History |
| 2024-03-01 12:19 pm Purchase |
2024-02-13 | 13G | PolyPid Ltd. PYPD |
Rosalind Advisors, Inc. | 415,800 9.950% |
415,800 (New Position) |
Filing History |
| 2024-02-22 4:28 pm Sale |
2023-12-31 | 13G | OptiNose, Inc. OPTN |
Rosalind Advisors, Inc. | 325,705 4.400% |
-103,295 (-24.08%) |
Filing History |
| 2024-02-20 1:42 pm Sale |
2023-12-31 | 13G | Guided Therapeutics, Inc. GTHP |
Rosalind Advisors, Inc. | 0 0.000% |
-2,338,740 (Position Closed) |
Filing History |
| 2024-02-20 1:38 pm Sale |
2023-12-31 | 13G | SIENTRA INC SIENQ |
Rosalind Advisors, Inc. | 0 0.000% |
-509,274 (Position Closed) |
Filing History |
| 2024-02-15 10:42 am Unchanged |
2023-12-31 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 4,575,385 9.200% |
0 (Unchanged) |
Filing History |
| 2024-02-14 9:40 pm Sale |
2023-12-31 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 4,575,385 9.200% |
-2,757,949 (-37.61%) |
Filing History |
| 2024-02-14 9:33 pm Unchanged |
2023-12-31 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 8,988,318 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 8:48 pm Purchase |
2023-12-31 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors, Inc. | 479,990 5.200% |
479,990 (New Position) |
Filing History |
| 2024-02-14 8:43 pm Purchase |
2023-12-31 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors, Inc. | 479,990 5.200% |
35,664 (+8.03%) |
Filing History |
| 2024-02-14 8:31 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 6,676,933 9.900% |
4,518,661 (+209.36%) |
Filing History |